Dirk van Lier (D van Lier)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Replacement Therapy

Angiotensin Converting Enzyme

Vascular Smooth Muscle Cells

Top Venues

ERJ open research

Journal of internal medicine

Pediatric transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Dirk van Lier, Benjamin Deniau, Karine Santos, Oliver Hartmann, Emmanuel Dudoignon, François Depret, Benoit Plaud, Pierre-Francois Laterre, Alexandre Mebazaa, Peter Pickkers
Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study. ERJ open research 9 (1) (2023)
Dirk van Lier, Benjamin Deniau, Karine Santos, Oliver Hartmann, Emmanuel Dudoignon, François Depret, Benoit Plaud, Pierre-Francois Laterre, Alexandre Mebazaa, Peter Pickkers
Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study. ERJ open research 9 (1) (2023)
Marieke Voet, Dirk van Lier, Joris Lemson, Alex Zarbock, Ignacio Malagon, Elisabeth A M Cornelissen, Peter Pickkers
Hemodynamics and urinary excretion of kidney-injury biomarkers in pediatric kidney transplantation. Pediatric transplantation (2023)
Dirk van Lier, Matthijs Kox, Karine Santos, Hans van der Hoeven, Janesh Pillay, Peter Pickkers
Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients. ERJ open research 7 (1) (2021)
Dirk van Lier, Matthijs Kox, Peter Pickkers
Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3. Journal of internal medicine 289 (6) (2020)